Timothy A. KOSS;Zoar Jacob ENGELMAN;Veijo T. SUORSA;Yegor D. SINELNIKOV;Michael Brick MARKHAM;Martin M. GRASSE;Kenneth M. MARTIN;Miriam H. TAIMISTO;Brice Arnault DE LA MENARDIERE;Mark GELFAND;Xian WEI
发明人:
Yegor D. SINELNIKOV,Zoar Jacob ENGELMAN,Mark GELFAND,Martin M. GRASSE,Timothy A. KOSS,Michael Brick MARKHAM,Kenneth M. MARTIN,Veijo T. SUORSA,Miriam H. TAIMISTO,Xian WEI,Brice Arnault DE LA MENARDIERE
申请号：
US16683071
公开号：
US20200093505A1
申请日:
2019.11.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods and devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation. The methods may be performed using an ultrasound ablation catheter. The methods may also include imaging using at least one ultrasound imaging catheter.
